Furthermore, as the CLSTN1 splice isoform levels, but not its transcription level, correlates with patient survival, we speculate that tipping the AKAP8 downstream target from CLSTN1-L to CLSTN1-S may be an effective strategy for the treatment of breast cancer. This evidence concerns the gene CLSTN1 and breast carcinoma.